Deep Learning-based HRCT Assessment of Baseline Disease Severity in the Deupirfenidone Elevate IPF Trial: Comparison With a Well-Characterised IPF Population

deupirfenidone (LYT-100) - PureTech

https://ats2026.d365.events/education/abstracts/abstracts/74222991-0535-425d-9e2f-a87ebb76ebaf

Camilla S. Graham, MD, MPH; Simon L F. Walsh, MD, PhD; Toby M. Maher, MD, MSc, PhD, FRCP; Amy Craster, BA; Muhunthan Thillai, MD, PhD; Elliott Bussell, PhD; David Golod, PhD; Philip L. Molyneaux, MD, PhD

Mar 3, 2026